SCHEMBL2565176

SCHEMBL2565176

CCOC(=O)c1cnc(N(C)CCc2cc3nc(-c4ccc(OC)nc4)nc(N4CCOCC4)c3s2)nc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 15/20 0.69
PIK3CD O00329 11/20 0.69
PIK3CB P42338 10/20 0.69
PIK3CG P48736 10/20 0.69
HDAC1 Q13547 8/20 0.69
HDAC2 Q92769 4/20 0.69
HDAC10 Q969S8 4/20 0.69
HDAC11 Q96DB2 4/20 0.69
HDAC6 Q9UBN7 3/20 0.69
HDAC3 O15379 3/20 0.69
MTOR P42345 3/20 0.69
PIK3R1 P27986 2/20 0.69
HDAC4 P56524 2/20 0.69
HDAC7 Q8WUI4 2/20 0.69
HDAC8 Q9BY41 2/20 0.69
HDAC9 Q9UKV0 2/20 0.69
HDAC5 Q9UQL6 2/20 0.69
NCOR2 Q9Y618 2/20 0.69
PRKDC P78527 1/20 0.69
KCNH2 Q12809 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1284788 0.93 PIK3CA (0.80) PIK3CAPIK3CDPIK3CBPIK3CGHDAC1
SCHEMBL30130765 0.93 PIK3CA (0.80) PIK3CAPIK3CDPIK3CBPIK3CGHDAC1
SCHEMBL2561934 0.91 PIK3CA (0.56) PIK3CAPIK3CDPIK3CBPIK3CGHDAC1
SCHEMBL2563916 0.90 HDAC1 (0.69) PIK3CAPIK3CDPIK3CBPIK3CGHDAC1
SCHEMBL2558754 0.89 HDAC1 (0.86) PIK3CAPIK3CDPIK3CBPIK3CGHDAC1
SCHEMBL1284675 0.88 PIK3CA (0.72) PIK3CAPIK3CDPIK3CBPIK3CGHDAC1
SCHEMBL30130774 0.88 PIK3CA (0.72) PIK3CAPIK3CDPIK3CBPIK3CGHDAC1
SCHEMBL30271532 0.87 PIK3CA (0.69) PIK3CAPIK3CDPIK3CBPIK3CGHDAC1
SCHEMBL1284344 0.87 PIK3CA (0.69) PIK3CAPIK3CDPIK3CBPIK3CGHDAC1
SCHEMBL1284929 0.86 PIK3CA (0.86) PIK3CAPIK3CDPIK3CBPIK3CGHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2557923-A1 TREATMENT OF CANCERS HAVING K-RAS MUTATIONS Curis, Inc. (US) 2013-02-20 EP disclosed
WO-2011130628-A1 TREATMENT OF CANCERS HAVING K-RAS MUTATIONS CURIS, INC. (US) 2011-10-20 WO disclosed